Vishnu Nagalapuram
@dr_vishnu_n
HemeOnc fellow @ouhsc @StephensonCC. IM @ UAB Montgomery.
ID: 936071203214696448
30-11-2017 03:15:41
502 Tweet
497 Followers
1,1K Following
Treatment of COVID-19 associated catastrophic APS with eculizumab. Another reason to get vaccinated! Congrats Bleeding and Clotting Disorders Institute UICOMP-IM Residency Program University of Illinois College of Medicine Peoria COVID-19 may potentiate antiphospholipid syndrome | JBM Dove Medical Press dovepress.com/a-case-report-…
Still feels surreal! Thrilled to have couples matched with my fiancé Vishnu Nagalapuram at University of Oklahoma! Am going into PCCM and he is going to Heme- Onc! Grateful and thankful for each and every one who supported us through this journey!
@titilopefasipe #ashapalooza #ASH21 Talking about sickle cell and 10 redefined. She absolutely rocked it! And remembering Hertz Nazaire #RIP
SO excited to see more novel gene therapy techniques & targets for #SCD at #ASH21, but I've noticed that there is significant variability across these trials with regards to eligibility based on the availability of an allogeneic transplant donor.🤔 Julie Kanter Alexis Thompson 1/
Complete resolution of severe VOE in individuals with #sicklecelldisease treated with lentiglobin therapy. #genetherapy for #SCD Thank you bluebird bio for keeping the faith for #sicklecelldisease NEJM ASH UAB Medicine nejm.org/doi/full/10.10…
Thank you JAMA Oncology for ✍️ my thoughts on similarities between ♟and 🦀! As an oncologist the mantras of chess have been unexpectedly relatable, but I am hoping to use my learnings against a more formidable opponent! 🦀 Mayo Clinic Hematology-Oncology Fellowship Hem-Onc Fellows Network bit.ly/3RKusvX
The care planning umbrella: The evolution of advance care planning. agsjournals.onlinelibrary.wiley.com/doi/10.1111/jg… American Geriatrics Society JAGS Rebecca Sudore ACP Decisions #Geriatrics #GeriOnc #PallOnc #PalliativeCare
I’m proud of these ⭐️ mentees Dr. Kumar and Dr. Gujju showing our work on #MachineLearning & #AI ability to predict survival in patients with DLBCL. Manuscript is under review currently #ASH23 #ASH2023 #lymsm Rafeh Naqash, MD OU Health Stephenson Cancer Center Adam Asch